The synthetic TRPML1 agonist, ML-SA1, rescues Alzheimer-related alterations of the endosomal-autophagic-lysosomal system
Attributed to:
Therapeutic targeting of impaired lysosomal flux in Alzheimer's disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Parent Publication: Journal of Cell Science